Record French damages award is a good sign for pharma patentees
Recent decision to award Eli Lilly a preliminary injunction and damages in case against a generic company demonstrates an increasingly pro-rights holder approach on the part of a key French court
To read more
Register for limited access
Register to receive our newsletter and gain limited access to subscriber content.
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the IAM experts.